Keyphrases
Bunyavirales
9%
COVID-19
31%
COVID-19 Vaccine
9%
Double-stranded RNA
22%
Ebola
38%
Ebola Virus
100%
Ebola Virus Infection
8%
Filovirus
32%
Fluor
9%
Host Factors
12%
Human Immunodeficiency Virus Type 1 (HIV-1)
10%
Human Respiratory Syncytial Virus (hRSV)
12%
Immune Escape
9%
Innate Immune Response
13%
Interferon Antagonism
11%
Interferon-α (IFN-α)
31%
International Committee on Taxonomy of Viruses
15%
Large Order
9%
Marburg Virus
26%
Molecular Mechanism
9%
Monoclonal Antibody
9%
Mononegavirales
28%
Mycobacterium Tuberculosis (M. tb)
9%
Negative-sense RNA Virus
11%
Neutralizing Antibodies
13%
Non-structural Protein
11%
NS1′
9%
Nucleocapsid Protein
14%
Nucleoprotein
33%
Phosphorylation
12%
Plasmonics
9%
Pregenomic RNA (pgRNA)
10%
Riboviria
9%
Rift Valley Fever Virus
12%
RIG-I-like Receptors
12%
RNA Binding
13%
RNA Packaging Signal
9%
SARS-CoV-2 Infection
12%
Stem-loop
11%
Taxonomic Update
9%
Viral
16%
Viral Infection
12%
Viral Polymerase
11%
Viral Proteins
36%
Viral Replication
14%
Viral RNA Synthesis
19%
Virus
31%
Virus Replication
19%
VP24
16%
VP35
55%
Immunology and Microbiology
Amino Terminal Sequence
7%
Binding Site
7%
Carboxy Terminal Sequence
20%
Cell Wall
6%
COVID-19
12%
Drug Resistance
6%
Ebola Virus
87%
Filoviridae
8%
Filovirus
28%
Fluor
6%
Glycoprotein
10%
Hemorrhagic Fever
8%
Host Factor
10%
Human Respiratory Syncytial Virus
12%
Immune Evasion
17%
Immune Response
19%
Infectious Agent
14%
Influenzavirus A
7%
Innate Immune System
19%
interferon
52%
Macrophage
9%
Marburgvirus
21%
Methylation
6%
Monoclonal Antibody
9%
Mycobacterium Tuberculosis
9%
Negative-Strand RNA Virus
9%
Neutralization
11%
Neutralizing Antibody
11%
Nuclear Import
7%
Nucleoprotein
33%
Peptides
8%
Phase Separation
7%
Protein Protein Interaction
6%
Rift Valley Fever Virus
12%
RIG-I
11%
RIG-I-like Receptor
11%
RNA Binding
9%
RNA Synthesis
18%
Severe Acute Respiratory Syndrome Coronavirus 2
34%
Spike
6%
Staphylococcus Aureus
6%
STAT1
9%
Transcription Factor Nrf2
6%
Untranslated Region
6%
Viral Disease
25%
Viral Protein
29%
Viral Replication
28%
Virulence Factor
6%
Virus
44%
Virus Nucleocapsid
8%
Biochemistry, Genetics and Molecular Biology
Active Site
7%
Binding Affinity
5%
Binding Site
8%
C-Terminus
19%
Capping Phenomenon
6%
Conformation
6%
Cryoelectron Microscopy
6%
Crystal Structure
7%
Double-Stranded RNA
20%
Dynamics
6%
Ebolavirus
77%
Filovirus
15%
Fluor
6%
Gene Expression
7%
Guanine Nucleotide Exchange Factor
5%
Human Immunodeficiency Virus 1
9%
Human Respiratory Syncytial Virus
12%
IFIT1
6%
Immune Evasion
12%
Immune Response
9%
Influenza A Virus
5%
Innate Immunity
6%
Interferon
38%
Karyopherin
10%
Marburgvirus
19%
N-Terminus
12%
Negative-Strand RNA Virus
6%
Neutralizing Antibody
6%
Nuclear Import
7%
Nucleoprotein
35%
Oligomerization
5%
Phase Separation
5%
Polymerase
15%
RIG-I-like Receptor
6%
RNA
36%
RNA Binding
17%
RNA Synthesis
17%
SARS Coronavirus
25%
Small Molecule
9%
STAT1
9%
Stem-Loop
9%
Synapsin I
14%
Transcription
9%
Transcription Factor Nrf2
12%
Tyrosine
6%
Viral Protein
26%
Virus Genome
5%
Virus Nucleocapsid
22%
Virus Replication
22%
X Ray
9%